Clinical trials
Hospitalization clinical trials
Below are recruiting hospitalization clinical trials, each written for real people, not researchers. We’re tracking 15,623 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT04987073Recruiting
Vitamin D type added for CYP24A1 vitamin D deficiency
This study tests a vitamin D-like medicine for people with a specific genetic cause of low active vitamin D (CYP24A1 deficiency). If you have the right gene change, it may help your body use vitamin D more normally.
Caen, NormandyAges 18 years+ - NCT05236946RecruitingPhase 3
Brain radiation timing study for gene-mutated lung cancer
This study compares giving brain radiation right away versus waiting, in people with lung cancer that has an EGFR or ALK gene change and has spread to the brain but causes no symptoms. It aims to see which approach helps control the brain cancer better and keeps quality of life stable.
Mumbai, MaharashtraAges 18–99 - NCT04831242Recruiting
Monitoring newborn health in intensive care
This study checks how a newborn’s body changes over time in an intensive care unit, using routine monitoring. Your child may benefit by being closely observed, and the results may help improve care for future newborns.
CambridgeAges Any age - NCT04935021RecruitingPhase 4
Study of ATTR cardiac amyloidosis in patients and gene carriers
This study looks at ATTR cardiac amyloidosis (a condition caused by an inherited protein change) in people who have the disease or carry the gene. It may help researchers learn how ATTR affects the heart and how care can be improved.
Hangzhou, ZhejiangAges 18–80 - NCT04936646Recruiting
Brain stimulation study for long-term nerve pain
This trial tests whether a form of brain stimulation (rTMS) can reduce chronic nerve pain that has lasted more than a year and hasn’t improved with standard treatments. It may help people whose usual pain medicines are stable but still not working well.
Grenoble, IsèreAges 18–80 - NCT05191121Enrolling by invitation
Rehab program to improve arm and trunk control after spinal injury
This trial helps people with recent traumatic spinal cord injury improve arm movement and trunk (upper body) stability using a training program that includes electrical stimulation. If you’re early after injury and can safely use stimulation, you may benefit from more controlled movement for daily tasks.
Englewood, ColoradoAges 18 years+ - NCT04922892Recruiting
Compare two parathyroid surgeries for severe kidney-related hormone imbalance
This trial compares two surgical approaches for severe secondary hyperparathyroidism caused by kidney disease: removing all parathyroid tissue alone versus removing it and moving some tissue back into the body. The study aims to see which approach works better and is safer for controlling the hormone problem.
NanjingAges 18–70 - NCT04833491Recruiting
Eye measurements before cataract surgery and vision quality after
This study uses very specific eye measurements done before cataract surgery to see how they relate to the clarity of vision after surgery. It may help surgeons choose the best surgical approach and improve visual outcomes.
HangzhouAges 2–90 - NCT04794582Recruiting
Preventing a belly hernia after first kidney transplant
This trial looks at ways to prevent an incisional hernia (a bulge at the surgical scar) after your first kidney transplant. If you’re getting a first transplant, joining could help test treatments or strategies that lower this post-surgery complication.
MadridAges 18 years+ - NCT04750122RecruitingPhase 1/Phase 2
Drug-screening guided treatment before surgery for HER2 breast cancer
This trial tests a treatment plan that is chosen using drug-testing in a lab (to see which medicines may work best) before surgery. It is for people with early-stage HER2-positive breast cancer, aiming to improve outcomes by guiding the right treatment early.
Beijing, Beijing MunicipalityAges 18–75 - NCT05013086RecruitingEarly Phase 1
Study of a targeted radioactive drug for αVβ3-positive tumors
This early-phase study tests whether a targeted radioactive medicine (177Lu-AB-3PRGD2) can shrink or control tumors that strongly match a specific target seen on special scans. It may help people whose current standard treatments are not working or are no longer working.
Beijing, Beijing MunicipalityAges 18–80 - NCT05000892RecruitingPhase 2
Immunotherapy plus chemotherapy before surgery for salivary cancer
This trial studies giving an immunotherapy drug (sintilimab) plus two chemotherapy medicines before surgery to shrink salivary gland cancer. The goal is to improve how well the cancer responds and is controlled, while still aiming for a cure through surgery.
Guangzhou, GuangdongAges 18–80 - NCT04848025Recruiting
Custom 3D stents made for blocked airways
This trial studies a computer-planned, custom-made 3D stent to open up narrow, blocked areas of the main airway near the chest. It may help reduce breathing trouble and cough, and prevent complications from the blockage.
Toulouse, ToulouseAges 18 years+ - NCT05124964Recruiting
Quality of life study for newly diagnosed brain germ cell tumors
This study looks at how life quality changes in children and young adults after a new diagnosis of a brain germ cell tumor. It may help doctors understand which supports improve day-to-day well-being.
BeijingAges 3–30 - NCT05088226RecruitingPhase 2
Ruxolitinib plus chidamide before transplant for high-risk leukemia
This Phase 2 study tests whether adding two medicines (ruxolitinib and chidamide) to a “conditioning regimen” before an allogeneic stem cell transplant improves outcomes for people with high-risk B-cell ALL. It may help prepare the body for transplant and reduce the chance of leukemia coming back.
Beijing, Beijing MunicipalityAges 12–65 - NCT05154305Recruiting
Rehab program for children after acute cancer treatment
This trial studies a multidisciplinary rehabilitation program to help children and teens recover and improve their physical fitness after acute cancer treatment. It may be useful if you’re not currently on cancer medicines and are in the follow-up period.
GhentAges 8–21 - NCT05076019Recruiting
Atorvastatin during heart valve surgery for patients over 60
This trial studies whether taking atorvastatin (a cholesterol medicine) around the time of surgical aortic valve replacement can improve outcomes. It is mainly for people who have not taken similar medicines recently and do not have certain heart rhythm or liver/kidney problems.
OdenseAges 60–95 - NCT04722900Recruiting
Study of children born to mothers with gestational diabetes
This study looks at children whose mothers did or did not have gestational diabetes during pregnancy. It will help researchers understand possible differences in children and how pregnancy diabetes may affect them.
TübingenAges 6–17 - NCT05233462Recruiting
Compare two spinal anesthesia bupivacaine dose methods for C-sections
This trial looks at whether adjusting the dose of bupivacaine by height works better than using a standard dose for spinal anesthesia during planned C-sections. It may help improve safety and comfort by aiming for the right level of numbing effect.
CaenAges 18–45 - NCT04871932Recruiting
Study of immune response to a COVID-19 vaccine
This trial studies how your immune system responds after a COVID-19 vaccine. It uses detailed blood tests to understand what changes happen in your immune cells and may help researchers improve future vaccines.
ShanghaiAges 18–50 - NCT05245591RecruitingPhase 2/Phase 3
Pentosan for bladder irritation after pelvic radiation
This trial studies whether pentosan polysulfate sodium can reduce bladder bleeding (hematuria) and urinary symptoms caused by radiation cystitis after pelvic cancer radiation. It may help people who are still having these bladder problems more than 6 months after radiation.
TaipeiAges 20 years+ - NCT04931537Recruiting
Testing early kidney marker tests for people with diabetes
This study looks for early warning signs in blood or other samples (using a special lab approach) to detect kidney problems sooner in people with diabetes. It may help patients and clinicians identify kidney risk earlier and follow changes over many years.
HangzhouAges 18–80 - NCT04900597Recruiting
Testing blended tube feeds on kids’ stomach function
This study compares how “blended” tube feeds affect stomach and upper digestive function in children who use a feeding tube. It may help doctors understand whether blended feeds change digestion in ways that matter for comfort and physiology.
Boston, MassachusettsAges 1 year+ - NCT05075512RecruitingPhase 2
Anlotinib with fulvestrant for advanced, HR-positive, HER2-negative breast cancer
This trial studies whether adding anlotinib (a targeted medicine) to fulvestrant (a hormone-blocking injection) can improve outcomes for people with advanced HR-positive, HER2-negative breast cancer. It focuses on safety and effectiveness when cancer has returned or progressed after hormone treatments.
Hangzhou, ZhejiangAges 18 years+
Hear when a new Hospitalization trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for hospitalization?
- Yes. Clin2 currently lists 15,623 recruiting hospitalization studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a hospitalization trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a hospitalization trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.